About the 3rd Precision Medicine in Inflammatory Bowel Disease Summit
IBD heterogeneity has provided significant challenges for drug developers in recent years. However, there is an answer!
Transformative advancements in disease understanding, AI-powered biomarker development, patient stratification, and advanced monitoring technologies are paving the way for a new era of precision therapies for patients in need.
The 3rd Precision Medicine in Inflammatory Bowel Disease Summit provides a unique platform to explore groundbreaking advancements, refine precision medicine strategies, and drive the development of transformative treatments - ensuring the right drug reaches the right patient, at the right time.
In an increasingly competitive landscape where leading players race to deliver the next breakthrough therapy, precision medicine stands as the most powerful tool to break efficacy barriers, enhance safety, and right drug, reaches the right patient, at the right time.
Join Your Peers to:
Unlock IBD heterogeneity with digital pathology and spatial biology, enhancing patient stratification and revealing actionable molecular targets to drive therapeutic breakthroughs for patients with unmet needs, with insights from
Smash the efficacy ceiling with diagnostic biomarkers to refine patient subtyping to ensure the right patient gets the right drug at the right time, by
Revolutionize clinical monitoring with advanced ultrasound technology and AI-driven imaging tools, enabling non-invasive surveillance to enhance clinical decision-making and refine treatment strategies, with key learnings from
Discover novel therapeutic targets and mechanisms of action, unlocking unprecedented opportunities to deliver transformative treatments and elevate standards of care, leveraging expertise from
Unleash the potential of combination therapies to amplify treatment efficacy, minimize adverse effects, and deliver synergistic solutions for more personalized and effective patient care, shaped by analysis from
Who Will You Meet?
Connecting you with a carefully curated group of 80+ senior decision-makers at the forefront of precision medicine for Inflammatory Bowel Disease, this event offers an unmatched opportunity to network with C-level executives, vice presidents, directors, heads, and senior scientists. Connect with leaders from major pharmaceutical companies, pioneering biotechs, renowned academic institutions, and leading service providers driving innovation in this dynamic field.
What Your Peers Have to Say
“Extremely well run and organized, excellent presentations, and ample time for discussion and networking”
2025 Speaker & Past Attendee, Paul Kayne, Vice President, Biological Sciences
“It was an intimate meeting with excellent representation from big pharma and biotech in the IBD space. I was able to have meaningful conversations with most attendees whether through round table discussions or social breaks.”
Past Speaker, Associate Director of Immunology